title: Prednisone used as treatment for rejection correlates with poor outcome.
authors.affiliation: Howard University Hospital, Washington, DC 20060.
authors.forename: R M
authors.initials: RM
authors.lastname: Toussaint
authors.forename: C O
authors.initials: CO
authors.lastname: Callender
authors.forename: G M
authors.initials: GM
authors.lastname: Dunston
authors.forename: J
authors.initials: J
authors.lastname: Flores
authors.forename: C S
authors.initials: CS
authors.lastname: Walters
authors.forename: D
authors.initials: D
authors.lastname: John
authors.forename: C
authors.initials: C
authors.lastname: Yeager
authors.forename: O
authors.initials: O
authors.lastname: Bond
authors.forename: C
authors.initials: C
authors.lastname: Thompson
authors.forename: J C
authors.initials: JC
authors.lastname: Gear
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D002102:Cadaver; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D011241:Prednisone / Q000627:therapeutic use*; D011379:Prognosis; D013156:Splenectomy; D014184:Transplantation, Homologous
chemical_list: D000961:Antilymphocyte Serum; D001379:Azathioprine; D011241:Prednisone